Nuvation Bio (NUVB) Market Capitalization: 2020-2025
Historic Market Capitalization for Nuvation Bio (NUVB) over the last 4 years, with Jun 2025 value amounting to $663.5 million.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Summit Therapeutics | 1,387.71B | 1,387.50B | - |
| 2 | BeOne Medicines | 458.68B | 457.16B | 1.15B |
| 3 | Vertex Pharmaceuticals | 102.37B | 99.35B | - |
| 4 | Benitec Biopharma | 65.38B | 65.31B | - |
| 5 | Regeneron Pharmaceuticals | 60.67B | 60.28B | - |
| 6 | Alnylam Pharmaceuticals | 60.53B | 62.66B | - |
| 7 | Argenx Se | 45.96B | 50.00B | - |
| 8 | INSMED | 26.50B | 27.40B | - |
| 9 | BioNTech SE | 25.15B | 17.24B | - |
| 10 | Nuvation Bio | 1.42B | 1.38B | 2.26M |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.27B |
| Jun 30, 2025 | 663.51M |
| Mar 31, 2025 | 596.07M |
| Dec 31, 2024 | 895.27M |
| Sep 30, 2024 | 570.77M |
| Jun 30, 2024 | 721.74M |
| Mar 31, 2024 | 797.33M |
| Dec 31, 2023 | 330.61M |
| Sep 30, 2023 | 293.39M |
| Jun 30, 2023 | 393.85M |
| Mar 31, 2023 | 363.21M |
| Dec 31, 2022 | 419.31M |